Request Demo
Last update 08 May 2025
Shanghai Laifu Life Science Technology Co., Ltd
Private Company|2013|Shanghai Shi, China
Private Company|2013|Shanghai Shi, China
Last update 08 May 2025
Overview
Tags
Neoplasms
Other Diseases
Respiratory Diseases
CAR-T
Mesenchymal stem cell therapy
Monoclonal antibody
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CN118184785
Patent MiningTarget |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20242375
探索人脐带间充质干细胞注射液治疗间质性肺病（ILD）的安全性、耐受性及初步有效性的开放性临床研究
[Translation] An open clinical study to explore the safety, tolerability and preliminary efficacy of human umbilical cord mesenchymal stem cell injection in the treatment of interstitial lung disease (ILD)
NCT06534528
An Open Clinical Study Exploring the Safety, Tolerability, and Preliminary Efficacy of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Interstitial Lung Disease (ILD)
CTR20221110
探索人脐带间充质干细胞注射液治疗特发性肺纤维化（IPF）的安全性、耐受性及初步有效性的开放性临床研究
[Translation] An open clinical study to explore the safety, tolerability and preliminary efficacy of human umbilical cord mesenchymal stem cell injection in the treatment of idiopathic pulmonary fibrosis (IPF)
100 Clinical Results associated with Shanghai Laifu Life Science Technology Co., Ltd
Login to view more data
Login to view more data
100 Deals associated with Shanghai Laifu Life Science Technology Co., Ltd
Login to view more data
100 Translational Medicine associated with Shanghai Laifu Life Science Technology Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 12 May 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
6
1
Preclinical
Phase 2 Clinical
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free